BCL2 and breast carcinoma: Expression analysis of BCL-2, p53 and BAX in breast cancer cell lines treated with F. falciforme 16563’asparaginase and Doxo showed that the expression levels of the antiapoptotic gene BCL-2 were singnificantly greater in negative samples of breast cancer cell lines than in treated cell lines(Fig. 10A).